a3ar agonist Search Results


90
BioIntervene Inc a 3 ar agonists
A 3 Ar Agonists, supplied by BioIntervene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a 3 ar agonists/product/BioIntervene Inc
Average 90 stars, based on 1 article reviews
a 3 ar agonists - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BioIntervene Inc a3ar agonists
The figure illustrates the several <t>A3AR</t> agonists use in different preclinical model of neuropathic pain of various origins.
A3ar Agonists, supplied by BioIntervene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a3ar agonists/product/BioIntervene Inc
Average 90 stars, based on 1 article reviews
a3ar agonists - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Can Fite Biopharma a 3 ar agonist 1-deoxy-1-[6-[[(iodophenyl)methyl] amino]-9h-purine-9-yl]-n-methyl-(-d-ribofuranuronamide) (ib-meca)
The figure illustrates the several <t>A3AR</t> agonists use in different preclinical model of neuropathic pain of various origins.
A 3 Ar Agonist 1 Deoxy 1 [6 [[(Iodophenyl)methyl] Amino] 9h Purine 9 Yl] N Methyl ( D Ribofuranuronamide) (Ib Meca), supplied by Can Fite Biopharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a 3 ar agonist 1-deoxy-1-[6-[[(iodophenyl)methyl] amino]-9h-purine-9-yl]-n-methyl-(-d-ribofuranuronamide) (ib-meca)/product/Can Fite Biopharma
Average 90 stars, based on 1 article reviews
a 3 ar agonist 1-deoxy-1-[6-[[(iodophenyl)methyl] amino]-9h-purine-9-yl]-n-methyl-(-d-ribofuranuronamide) (ib-meca) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier






Image Search Results


The figure illustrates the several A3AR agonists use in different preclinical model of neuropathic pain of various origins.

Journal: Frontiers in Pharmacology

Article Title: Adenosine Metabotropic Receptors in Chronic Pain Management

doi: 10.3389/fphar.2021.651038

Figure Lengend Snippet: The figure illustrates the several A3AR agonists use in different preclinical model of neuropathic pain of various origins.

Article Snippet: DS is founder of BioIntervene, Inc., a company developing A3AR agonists for clinical use.

Techniques: